Harness Cutting-Edge Genome Editing & Delivery Technologies to Accelerate Safe, Precise & Regulatory-Compliant Therapies From Discovery to the Clinic
Welcome to the 6th Genome Editing Therapeutics Summit
VIEW THE NEW AGENDA
2025 has been industry-defining for the genome editing space. With baby KJ successfully receiving the world’s first personalized CRISPR therapy, alongside continued innovation across in vivo and base editing, and rapid ex vivo clinical progress, the field stands at a pivotal juncture, ready to unlock the transformative potential of both established assets, and cutting-edge breakthroughs.
In an effort to capture this excitement, spotlight innovation and propel clinical progress, the 6th Genome Editing Therapeutics Summit returns to Boston. Addressing challenges and advancements in the application and delivery of novel gene editing technologies, including base, prime, multiplex, epigenome editing and more, this forum serves as your lens into the future of genome editing.
Showcasing both clinical advances and cutting-edge technologies from Metagenomi, Editas Medicine, University of Pennsylvania, nChromaBio, and Beam Therapeutics, this meeting will provide you with the critical learnings needed to optimize safety and durability, while building a robust clinical strategy to fast-track best-in-class therapeutics to more patients in need.
Your World-Class Speaker Faculty
“Each year, this meeting offers a unique platform to share cutting-edge insights and foster collaborations in the rapidly evolving field of genome editing. Its focus on overcoming delivery challenges remains both timely and critical for advancing the next generation of therapies”
Rammohan Devulapally, Director, Head, Non-Viral Delivery, Life Edit Therapeutics, 2025 Speaker
Industry-Leading Companies Attending
Proud to Partner With
“I built connections with others in the industry and engaged in dialogue around the questions that we still need to address”
Judith Newmark, Associate Director, In Vivo Gene Editing, Pharmacology & Toxicology, Editas Medicine, 2024 Attendee